Lansoprazole 15/30/Juniour Tablet

Lansoprazole is presented as orally disintegrating tablets and belongs to the class of proton pump inhibitor. Its standard indications include gastro-oesophageal reflux disease and peptic ulcer disease, as determined by a prescribing clinician.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.